Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Oncology|January 4, 2012
Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case reportTadashi Inuzuka, Hiroki Nishikawa, Akira Sekikawa, et al.
Cancers|December 28, 2019
Dose Intensity/Body Surface Area Ratio is a Novel Marker Useful for Predicting Response to Lenvatinib against Hepatocellular CarcinomaYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
International Journal of Oncology|September 19, 2014
Comparison of standard-dose and half‑dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysisHiroki Nishikawa, Yukio Osaki, Masatsugu Endo, et al.
Anticancer Research|June 13, 2014
Clinical efficacy of non-transplant therapies in patients with hepatocellular carcinoma with Child-Pugh C liver cirrhosisHiroki Nishikawa, Ryuichi Kita, Toru Kimura, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 21, 2012
Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patientsHiroki Nishikawa, Yukio Osaki, Eriko Iguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinomaHaruhiko Takeda, Hiroki Nishikawa, Eriko Iguchi, et al.
World Journal of Gastroenterology|April 12, 2012
Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinomaHiroki Nishikawa, Yukio Osaki, Tadashi Inuzuka, et al.
Journal of Gastroenterology|October 16, 2012
Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomesHiroki Nishikawa, Yukio Osaki, Eriko Iguchi, et al.
Oncology Reports|November 14, 2013
Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinomaHiroki Nishikawa, Yukio Osaki, Ryuichi Kita, et al.
Case Reports in Oncology|July 9, 2011
A case of advanced hepatocellular carcinoma with portal vein tumor thrombus refractory to epirubicin that showed marked decrease in tumor markers after transcatheter arterial infusion with miriplatinHiroki Nishikawa, Tadashi Inuzuka, Haruhiko Takeda, et al.
Pageof 8